FMO3 antibody (AA 81-130)

Catalog No. ABIN6754938

The Rabbit Polyclonal anti-FMO3 antibody has been validated for WB, IHC and IHC (p). It is suitable to detect FMO3 in samples from Human, Rat, Cow, Dog, Horse and Xenopus laevis.

Quick Overview for FMO3 antibody (AA 81-130) (ABIN6754938)

Target: FMO3 (Flavin Containing Monooxygenase 3 (FMO3))

Reactivity: Human, Rat, Cow, Dog, Horse, Xenopus laevis

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FMO3 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Product Details anti-FMO3 Antibody

Binding Specificity: AA 81-130

Brand: IHC-plus™

Specificity: Human FMO3

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa81-130 of human FMO3 (P31513, NP_001002294). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Marmoset, Elephant, Dog, Bovine, Xenopus (100%), Monkey, Galago, Mouse, Rabbit, Opossum (92%), Bat, Guinea pig (90%), Rat, Horse (85%).

Type of Immunogen: Synthetic peptide

Isotype: IgG

Application Details

Application Notes: Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: After adding water, will consist of PBS buffer with 2 % sucrose

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handling Advice: Avoid repeat freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Target Details for FMO3

Target: FMO3 (Flavin Containing Monooxygenase 3 (FMO3))

Alternative Name: FMO3

Background: Name/Gene ID: FMO3

Synonyms: FMO3, DJ127D3.1, FMO 3, FMOII, TMAU, Trimethylamine monooxygenase, Dimethylaniline oxidase 3, FMO form 2, FMO II

Gene ID: 2328

NCBI Accession: NP_001002294